In May, Fox Chase opened the region’s first clinic dedicated to treating patients with a rare and aggressive form of breast cancer. The Inflammatory Breast Cancer Clinic is led by Massimo Cristofanilli, who joined the Center in January as chairman of the department of medical oncology.
“Patients with inflammatory breast cancer often face challenging odds—first to be promptly and accurately diagnosed and then to receive the most effective treatment,” Cristofanilli says. “With the opening of this clinic, Fox Chase is dedicating itself to improving both diagnosis and care for inflammatory breast cancer patients.”
Cristofanilli comes from the University of Texas M.D. Anderson Cancer Center, where he founded and led the Morgan Welch Inflammatory Breast Cancer Program and Clinic, which treats more cases of the disease than any other facility in the world.
Inflammatory breast cancer accounts for only about 1 percent of breast cancers in the United States and can be difficult to diagnose, as it rarely causes a lump and may not appear on a mammogram.
Pat Halpin-Murphy, president and co-founder of the Pennsylvania Breast Cancer Coalition, and Patti Bradfield, president of the Inflammatory Breast Cancer Foundation, were among the guests who celebrated the opening of the clinic at the Women’s Cancer Center at Fox Chase.